Valion Bio, Inc. (VBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 448.56B |
| Enterprise Value | 448.56B |
| P/E Ratio | -8.45 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 0.62 |
| Price/Book Ratio | 1.4 |
| Enterprise/Revenue | 0.16 |
| Enterprise/EBITDA | 0.28 |
Fiscal Year
| Fiscal Year | March 31, 2021 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.46 |
| Operating Margin | -1.42 |
AD
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.19 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | -880,851 |
| Net Income | -880,851 |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 1.28M |
| Total Cash/Share | 0.01 |
| Total Debt | 500,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 0.57 |
| Book Value Per Share | 0.3 |
Price History
| 52-Week Change | -92.98 |
| 52-Week High | 5.6 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 0.48 |
| Moving Average 200 Days | 1.13 |
Statistics
| Average Volume | 571,753 |
| Shares Outstanding | 4.14M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 20, 2016 |
AD
